Could NPDR Be Treated Orally? - Top-Institutions - MDSpire

Could NPDR Be Treated Orally?

Phase 1b results for danegaptide indicate promising safety profile in patients with non-proliferative diabetic retinopathy and macular edema

  • March 24, 2026

  • 5 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts Eye and Ear Infirmary
    Massachusetts Eye and Ear Infirmary

    Boston, MA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Clinical Trials

  • #2

    Bascom Palmer Eye Institute
    Bascom Palmer Eye Institute

    Miami, FL

    Key Differentiators

    • Ophthalmology
    • Retina
    • Clinical Research

  • #3

    Johns Hopkins Wilmer Eye Institute
    Johns Hopkins Wilmer Eye Institute

    Baltimore, MD

    Key Differentiators

    • Ophthalmology
    • Retina
    • Translational Research

  • #4

    University of California, San Francisco (UCSF) Department of Ophthalmology
    University of California, San Francisco (UCSF) Department of Ophthalmology

    San Francisco, CA

    Key Differentiators

    • Ophthalmology
    • Retina
    • Clinical Trials

  • #5

    Moorfields Eye Hospital
    Moorfields Eye Hospital

    London, England

    Key Differentiators

    • Ophthalmology
    • Retina
    • Clinical Research

Original Source(s)

Could NPDR Be Treated Orally?

  • March 24, 2026

Related Content

Beyond the Diopter: Evolving Your Framework for Refractive Surgery Planning

Corneal health, axial length, and long-term ocular preservation are helpful guides for every refractive conversation

Clinical outcomes of weekly adalimumab in refractory non-infectious paediatric uveitis and the role of serum drug levels and anti-adalimumab antibodies

Vitamin D May Reflect Myopia Risk

Narrative review linked lower vitamin D levels to greater myopia risk and higher omega-3 intake to lower risk, though outdoor exposure may explain the vitamin D association.